Related Experiment Videos
Treatment with AC pulsed electromagnetic fields improves olfactory function in Parkinson's disease
1Department of Neuroscience at the Institute for Biomedical Engineering and Rehabilitation Services of Touro College, Dix Hills, NY 11746, USA.
The International Journal of Neuroscience
|June 18, 1999
Summary
Transcranial pulsed electromagnetic fields (EMFs) may restore smell in Parkinson's disease (PD) patients. This therapy, particularly at 7 Hz, potentially activates dopamine D2 receptors in the olfactory bulb, improving olfactory function.
Area of Science:
- Neuroscience
- Biophysics
Background:
- Olfactory dysfunction is a common early symptom of Parkinson's disease (PD), preceding motor deficits.
- The exact cause of smell loss in PD is unknown, though Lewy bodies in the olfactory bulb suggest pathology.
- Dopaminergic drugs do not typically improve olfactory deficits in PD patients.
Observation:
- Two medicated PD patients with long-standing smell dysfunction experienced smell recovery during transcranial AC pulsed electromagnetic field (EMF) therapy.
- Smell improvement coincided with yawning episodes, suggesting dopamine D2 receptor involvement.
- Enhanced smell perception occurred specifically during 7 Hz EMF administration.
Findings:
- Therapeutic application of low-intensity (picotesla flux density) 7 Hz EMFs may restore olfactory function in PD.
- The mechanism may involve the activation of upregulated dopamine D2 receptors in the olfactory bulb via released dopamine.
- The frequency-dependent nature of the response suggests a cyclotron resonance mechanism.
Implications:
- Pulsed electromagnetic fields offer a potential novel therapeutic strategy for olfactory dysfunction in Parkinson's disease.
- This finding highlights the role of dopamine D2 receptors in the olfactory bulb and their potential modulation by EMFs.
- Further research into frequency-specific EMF effects could lead to targeted treatments for neurodegenerative disorders.